Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth

Toshiaki Fushimi, Timothy P. O'Connor, Ronald Crystal

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The human CXC chemokine, stromal cell-derived factor 1 (SDF-1α), is known to function in vitro as a chemotactic factor for lymphocytes, monocytes, and dendritic cells. In the context that dendritic cells are powerful antigen-presenting cells, we hypothesized that adenoviral gene transfer of SDF-1α to tumors might inhibit growth of preexisting tumors through attracting dendritic cells to the tumor. AdSDF-1α mediated the expression of SDF-1α mRNA and protein in A549 cells in vitro, and the supernatant of the AdSDF-1α-infected A549 cells showed chemotactic activity for dendritic cells. When syngeneic murine CT26 colon carcinoma tumors (BALB/c) and B16 melanoma and Lewis lung cell carcinoma (C57B1/6) were injected with AdSDF-1α (5 × 108 plaque-forming units), there was an accumulation of dendritic cells and CD8+ cells within the tumor and significant inhibition of tumor growth compared with tumors injected with PBS or AdNull (control vector). The injection of AdSDF-1α into tumors induced the inflammatory enlargement and the accumulation of dendritic cells in the draining lymph node. Intratumoral AdSDF-1α administration elicited tumor-specific CTLs and adoptive transfer of splenocytes from AdSDF-1α-treated mice resulted in the elongation of survival after tumor challenge. Interestingly, in wild-type and CD4-/- mice but not in CD8-/- mice, AdSDF-1α inhibited the growth of the tumor. These observations suggest that adenoviral gene transfer of SDF-1α may be a useful strategy to accumulate dendritic cells in tumors and evoke antitumor immune responses to inhibit tumor growth.

Original languageEnglish
Pages (from-to)3513-3522
Number of pages10
JournalCancer Research
Volume66
Issue number7
DOIs
Publication statusPublished - 1 Apr 2006
Externally publishedYes

Fingerprint

Chemokine CXCL12
Dendritic Cells
Growth
Genes
Neoplasms
Lewis Lung Carcinoma
CXC Chemokines
Experimental Melanomas
Adoptive Transfer
Antigen-Presenting Cells
Monocytes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth. / Fushimi, Toshiaki; O'Connor, Timothy P.; Crystal, Ronald.

In: Cancer Research, Vol. 66, No. 7, 01.04.2006, p. 3513-3522.

Research output: Contribution to journalArticle

@article{8dfaff6f46e64d0d8589f143c04b033a,
title = "Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth",
abstract = "The human CXC chemokine, stromal cell-derived factor 1 (SDF-1α), is known to function in vitro as a chemotactic factor for lymphocytes, monocytes, and dendritic cells. In the context that dendritic cells are powerful antigen-presenting cells, we hypothesized that adenoviral gene transfer of SDF-1α to tumors might inhibit growth of preexisting tumors through attracting dendritic cells to the tumor. AdSDF-1α mediated the expression of SDF-1α mRNA and protein in A549 cells in vitro, and the supernatant of the AdSDF-1α-infected A549 cells showed chemotactic activity for dendritic cells. When syngeneic murine CT26 colon carcinoma tumors (BALB/c) and B16 melanoma and Lewis lung cell carcinoma (C57B1/6) were injected with AdSDF-1α (5 × 108 plaque-forming units), there was an accumulation of dendritic cells and CD8+ cells within the tumor and significant inhibition of tumor growth compared with tumors injected with PBS or AdNull (control vector). The injection of AdSDF-1α into tumors induced the inflammatory enlargement and the accumulation of dendritic cells in the draining lymph node. Intratumoral AdSDF-1α administration elicited tumor-specific CTLs and adoptive transfer of splenocytes from AdSDF-1α-treated mice resulted in the elongation of survival after tumor challenge. Interestingly, in wild-type and CD4-/- mice but not in CD8-/- mice, AdSDF-1α inhibited the growth of the tumor. These observations suggest that adenoviral gene transfer of SDF-1α may be a useful strategy to accumulate dendritic cells in tumors and evoke antitumor immune responses to inhibit tumor growth.",
author = "Toshiaki Fushimi and O'Connor, {Timothy P.} and Ronald Crystal",
year = "2006",
month = "4",
day = "1",
doi = "10.1158/0008-5472.CAN-05-1493",
language = "English",
volume = "66",
pages = "3513--3522",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth

AU - Fushimi, Toshiaki

AU - O'Connor, Timothy P.

AU - Crystal, Ronald

PY - 2006/4/1

Y1 - 2006/4/1

N2 - The human CXC chemokine, stromal cell-derived factor 1 (SDF-1α), is known to function in vitro as a chemotactic factor for lymphocytes, monocytes, and dendritic cells. In the context that dendritic cells are powerful antigen-presenting cells, we hypothesized that adenoviral gene transfer of SDF-1α to tumors might inhibit growth of preexisting tumors through attracting dendritic cells to the tumor. AdSDF-1α mediated the expression of SDF-1α mRNA and protein in A549 cells in vitro, and the supernatant of the AdSDF-1α-infected A549 cells showed chemotactic activity for dendritic cells. When syngeneic murine CT26 colon carcinoma tumors (BALB/c) and B16 melanoma and Lewis lung cell carcinoma (C57B1/6) were injected with AdSDF-1α (5 × 108 plaque-forming units), there was an accumulation of dendritic cells and CD8+ cells within the tumor and significant inhibition of tumor growth compared with tumors injected with PBS or AdNull (control vector). The injection of AdSDF-1α into tumors induced the inflammatory enlargement and the accumulation of dendritic cells in the draining lymph node. Intratumoral AdSDF-1α administration elicited tumor-specific CTLs and adoptive transfer of splenocytes from AdSDF-1α-treated mice resulted in the elongation of survival after tumor challenge. Interestingly, in wild-type and CD4-/- mice but not in CD8-/- mice, AdSDF-1α inhibited the growth of the tumor. These observations suggest that adenoviral gene transfer of SDF-1α may be a useful strategy to accumulate dendritic cells in tumors and evoke antitumor immune responses to inhibit tumor growth.

AB - The human CXC chemokine, stromal cell-derived factor 1 (SDF-1α), is known to function in vitro as a chemotactic factor for lymphocytes, monocytes, and dendritic cells. In the context that dendritic cells are powerful antigen-presenting cells, we hypothesized that adenoviral gene transfer of SDF-1α to tumors might inhibit growth of preexisting tumors through attracting dendritic cells to the tumor. AdSDF-1α mediated the expression of SDF-1α mRNA and protein in A549 cells in vitro, and the supernatant of the AdSDF-1α-infected A549 cells showed chemotactic activity for dendritic cells. When syngeneic murine CT26 colon carcinoma tumors (BALB/c) and B16 melanoma and Lewis lung cell carcinoma (C57B1/6) were injected with AdSDF-1α (5 × 108 plaque-forming units), there was an accumulation of dendritic cells and CD8+ cells within the tumor and significant inhibition of tumor growth compared with tumors injected with PBS or AdNull (control vector). The injection of AdSDF-1α into tumors induced the inflammatory enlargement and the accumulation of dendritic cells in the draining lymph node. Intratumoral AdSDF-1α administration elicited tumor-specific CTLs and adoptive transfer of splenocytes from AdSDF-1α-treated mice resulted in the elongation of survival after tumor challenge. Interestingly, in wild-type and CD4-/- mice but not in CD8-/- mice, AdSDF-1α inhibited the growth of the tumor. These observations suggest that adenoviral gene transfer of SDF-1α may be a useful strategy to accumulate dendritic cells in tumors and evoke antitumor immune responses to inhibit tumor growth.

UR - http://www.scopus.com/inward/record.url?scp=33645746888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645746888&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-1493

DO - 10.1158/0008-5472.CAN-05-1493

M3 - Article

C2 - 16585175

AN - SCOPUS:33645746888

VL - 66

SP - 3513

EP - 3522

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 7

ER -